Contact VaxLiant:

Our portfolio of ready-to-use and fully customizable adjuvants enable you to more easily:

A new generation of advancing vaccines

Vaxliant Vaccine

VaxLiant is a new joint venture designed to modernize how vaccines deliver antigens to prevent disease.

We provide innovative antigen-delivery systems and support that give the flexibility you need to develop and commercialize safe, effective vaccines. 

Our portfolio of ready-to-use ENABL® adjuvants and fully customizable BioMize® antigen-delivery systems are backed by a team of technical and marketing experts. Together, they offer you unparalleled adaptability to streamline development of vaccines that protect against disease.